Search

everythinglearnresearchcommunity

for

Search:↓

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Minoxidil with propranolol and diuretics lowers blood pressure but causes fluid retention and hair growth.

Lower TNF-α levels in PRP may predict better treatment outcomes for bladder conditions.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Dihydrotestosterone (DHT) increases oil production in skin cells by activating mTOR, and mTOR inhibitors can reduce this effect.

Developing microRNA-based treatments is hard but has potential.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

CTP-543 is generally safe for treating alopecia areata.

Mirex seems to promote a unique group of skin cells different from those affected by another tumor promoter, TPA.

Various medications and vaccines can cause serious side effects.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

Adding a second method to PROTACs could improve cancer treatment.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

A new engineered treatment shows promise in curing heart fibrosis.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Brassinosteroids may be useful in treating cancer, infections, and other diseases.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Early diagnosis and treatment of TPP can prevent complications.

Retinoids can help treat skin pigmentation disorders by affecting melanin production.